What is Perrigo Company plc (PRGO)?

Perrigo Company plc (PRGO) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is PRGO's price-to-earnings (PE) ratio?

PRGO's trailing twelve-month PE ratio is -1.28, based on current price and earnings per share data available on Stocks360.

Does PRGO pay a dividend?

Yes. PRGO has a trailing twelve-month dividend yield of 0.07%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Perrigo Company plc (PRGO)

Stock analysis · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

Market Cap

N/A

PE (TTM)

-1.28

EPS (TTM)

N/A

Dividend Yield

7.24%

Beta

0.54

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Perrigo Company plc (PRGO) is a publicly traded company in the Healthcare sector. Trailing PE -1.28. Dividend yield 7.24%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $21.60 2026-10-27 · $16.02 (-25.83%)

Earnings

Most Recent

Aug 5, 2026

EPS $0.50 vs est. $0.39

Beat by $0.11

Next Earnings

Nov 4, 2026

EPS estimate $0.51

Proprietary Signals

Signal snapshot temporarily unavailable.

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start,…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-1.28×
P/S (TTM)	0.53×
P/B	0.89×
PEG	0.00×
P/FCF (TTM)	12.67×
EV / EBITDA	-4.89×
EV / Sales	1.23×
Earnings Yield	-77.85%
Free Cash Flow Yield	7.89%
Dividend Yield	7.24%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$5.11B
Revenue (TTM)	$4.14B
Net Income (TTM)	-$1.73B
Free Cash Flow (TTM)	$333.47M
Net Debt	$2.90B
Working Capital	$1.40B
Gross Margin	33.26%
Operating Margin	5.19%
Net Margin	-41.85%
Return on Equity	-55.97%
Return on Invested Capital	3.27%